Deals
Novartis and Molecular Partners Finalize $230 Million Pact for New Class of COVID-19 Antivirals
2022-01-19
Japan’s Ono Pharmaceutical Expands Collab with Neurimmune to Discover Antibodies for Neurodegenerative Disorders
2022-01-18
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02